spacer
home > pmps > autumn 2018 > connecting medications
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Connecting Medications

Medication noncompliance is becoming an increasingly focussed concern in the healthcare sector for diverse reasons. Various studies targeting this issue in recent years have confirmed a particular picture: if the majority of research outcomes are correct and more than 50% of patients do not take their medications as prescribed, the economic and personal costs of inadequate patient adherence are enormous (1). In the US alone, the costs of medication noncompliance to the healthcare system are estimated to range between US $100 billion and US $290 billion annually (2). Furthermore, approximately 125,000 deaths and more than 10% of US hospitalisations per year are directly linked to nonadherence reasons (3). In addition to the adverse effects on public or private healthcare systems, medication noncompliance significantly impacts the profitability of pharmaceutical manufacturers.

Changing Traditional Business Models

Increasing cost pressures on healthcare systems and pharma companies from the market or policymakers, stringent regulatory requirements, and progressive digitalisation are massively changing traditional business models. From a blockbuster-driven past, a clear trend towards a pharma industry increasingly committed to producing value-added pharmaceuticals is now visibly emerging. Outcome-based drug pricing may help the pharma industry justify expensive therapies that often cost thousands of euros or dollars a month. On the other hand, healthcare systems are looking for ways to become more efficient by only paying the costs of medicines with proven positive effects. In this context, patient behaviour is of particular importance, as adherence to the prescribed medication decisively contributes to therapy, as well as, ultimately, economic success in clinical trials and commercial products.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Mathias Held is Business Development Manager for Patient Compliance Monitoring Solutions at Schreiner MediPharm, a business unit of Schreiner Group. He is in charge of developing new markets and business opportunities with a strong focus on smart packaging. Mathias has a degree in media technology from the Leipzig University of Applied Sciences, Germany.
spacer
Mathias Held
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm accelerates strategy to broaden service offering into commercial manufacturing

MedPharm Ltd, a leading contract provider of topical and transdermal product design and development services, has announced two new appointments to its Board to support plans to grow its commercial manufacturing services.
More info >>

White Papers

Microalgae Culture Using the DASGIP® PBR4 Module for Illumination with a New Brunswick™ CelliGen® 310 Stirred-tank Bioreactor

Eppendorf

The number of bioprocess applications for microalgae has increased in recent years, particularly in the fi eld of biofuel production. The combination of the New Brunswick CelliGen 310 stirred-tank bioreactor and the DASGIP LED Illumination System creates a bioreactor setup which is capable of supporting high density microalgal growth. Using the stand-alone Eppendorf DASGIP PBR4 Module, LED illumination spectra and intensities can be controlled for optimal support of all types of chlorophylls and carotenoids. For this study in which high density culture of up to 1.5 x 107 cells/mL was achieved, the unicellular freshwater alga, Dunaliella tertiolecta, was used.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement